Literature DB >> 8427710

Defensins reduce the barrier integrity of a cultured epithelial monolayer without cytotoxicity.

S D Nygaard1, T Ganz, M W Peterson.   

Abstract

Polymorphonuclear leukocytes (PMN) contribute to epithelial injury at sites of inflammation, but their mechanisms of action are incompletely understood. PMN can injure target tissues by oxidative and nonoxidative mechanisms. Included in the nonoxidative mechanisms are defensins (DEF), small (3.5 to 4.0 kD), arginine- and cysteine-rich polypeptides. DEF are bactericidal, fungicidal, viricidal, and tumoricidal, but their ability to contribute to inflammatory injury has not been extensively evaluated. One marker of inflammatory injury is disrupted epithelial barrier integrity. Using Madin-Darby canine kidney (MDCK) epithelial monolayers, we measured the effect of both human and rabbit DEF on barrier integrity using mannitol permeability (Pmann) and transepithelial electrical resistance (Rt). Human DEF (HNP1-3, 2:2:1 molar ratio) increased Pmann in a time- and concentration-dependent manner and Rt fell progressively over a 48-h period after exposure of monolayers to HNP1-3. Rabbit DEF peptide 1 (NP-1) also increased Pmann, but rabbit peptide 5 (NP-5) had no effect on Pmann. To investigate the role of charge, HNP1-3 was added to the monolayers with the polyanions heparin or sulfated dextran. Heparin and sulfated dextran only partially inhibited the increase in Pmann. Fetal bovine serum (FBS), however, completely inhibited the effect of HNP1-3, but this protection was only partially explained by the anionic protein, albumin. The FBS protection was time dependent and was present when FBS was added up to 16 h after exposure to HNP1-3. While both HNP1-3 and NP-1 increased epithelial permeability, neither were cytolytic to MDCK cells as measured by lactate dehydrogenase release.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427710     DOI: 10.1165/ajrcmb/8.2.193

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  9 in total

1.  Induction of a rat enteric defensin gene by hemorrhagic shock.

Authors:  M R Condon; A Viera; M D'Alessio; G Diamond
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Dynamic changes in neutrophil defensins during endotoxemia.

Authors:  M E Klut; B A Whalen; J C Hogg
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 3.  Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury.

Authors:  Rachel L Zemans; Sean P Colgan; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

Review 4.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

Review 5.  New insights into the mechanisms of pulmonary edema in acute lung injury.

Authors:  Raquel Herrero; Gema Sanchez; Jose Angel Lorente
Journal:  Ann Transl Med       Date:  2018-01

6.  Human Alpha-Defensin HNP1 Increases HIV Traversal of the Epithelial Barrier: A Potential Role in STI-Mediated Enhancement of HIV Transmission.

Authors:  Kimyata Valere; Aprille Rapista; Eliseo Eugenin; Wuyuan Lu; Theresa L Chang
Journal:  Viral Immunol       Date:  2015-09-17       Impact factor: 2.257

7.  Immunohistochemical localization of defensin in human coronary vessels.

Authors:  E S Barnathan; P N Raghunath; J E Tomaszewski; T Ganz; D B Cines
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 8.  Cathepsin G: roles in antigen presentation and beyond.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; Bernhard O Boehm; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2009-11-11       Impact factor: 4.407

9.  Differential inhibition of polymorphonuclear leukocyte recruitment in vivo by dextran sulphate and fucoidan.

Authors:  N V Osselaer; M Rampart; A G Herman
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.